C Labrid

598 total citations
35 papers, 510 citations indexed

About

C Labrid is a scholar working on Molecular Biology, Organic Chemistry and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, C Labrid has authored 35 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Organic Chemistry and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in C Labrid's work include Receptor Mechanisms and Signaling (6 papers), Cardiac electrophysiology and arrhythmias (5 papers) and Synthesis and Biological Evaluation (4 papers). C Labrid is often cited by papers focused on Receptor Mechanisms and Signaling (6 papers), Cardiac electrophysiology and arrhythmias (5 papers) and Synthesis and Biological Evaluation (4 papers). C Labrid collaborates with scholars based in France. C Labrid's co-authors include Catherine Harpey, P Duchêne-Marullaz, A Kamoun, E. Mocaër, Jean Mironneau, Ludivine Perdrix, A. Crastes de Paulet, M. Dämon, Frédéric S. Michel and Bertrand Beau and has published in prestigious journals such as Journal of Medicinal Chemistry, The British Journal of Psychiatry and The American Journal of Cardiology.

In The Last Decade

C Labrid

33 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C Labrid France	12	204	180	88	56	54	35	510
Allen W. Gomoll United States	12	165 0.8×	257 1.4×	49 0.6×	37 0.7×	60 1.1×	38	558
L. H. Smith United States	10	213 1.0×	171 0.9×	76 0.9×	73 1.3×	41 0.8×	29	637
K.W. Dungan United States	12	171 0.8×	138 0.8×	76 0.9×	40 0.7×	42 0.8×	23	505
Giudicelli Jf France	12	122 0.6×	256 1.4×	44 0.5×	66 1.2×	59 1.1×	77	543
C Richer France	16	231 1.1×	395 2.2×	86 1.0×	68 1.2×	70 1.3×	46	737
Akiko Hof Switzerland	12	294 1.4×	235 1.3×	197 2.2×	61 1.1×	51 0.9×	29	604
P Duchêne-Marullaz France	15	285 1.4×	407 2.3×	112 1.3×	58 1.0×	33 0.6×	109	676
R Méndez Mexico	13	225 1.1×	427 2.4×	86 1.0×	31 0.6×	34 0.6×	30	650
Kanoo Hosoki Japan	11	174 0.9×	93 0.5×	55 0.6×	100 1.8×	39 0.7×	64	481
John F. Waterfall United Kingdom	14	307 1.5×	84 0.5×	136 1.5×	27 0.5×	59 1.1×	34	585

Countries citing papers authored by C Labrid

Since Specialization

Citations

This map shows the geographic impact of C Labrid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Labrid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Labrid more than expected).

Fields of papers citing papers by C Labrid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Labrid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Labrid. The network helps show where C Labrid may publish in the future.

Co-authorship network of co-authors of C Labrid

This figure shows the co-authorship network connecting the top 25 collaborators of C Labrid. A scholar is included among the top collaborators of C Labrid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Labrid. C Labrid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Labrid, C, E. Mocaër, & A Kamoun. (1992). Neurochemical and Pharmacological Properties of Tianeptine, A Novel Antidepressant. The British Journal of Psychiatry. 160(S15). 56–60. 35 indexed citations

Platzer, N., et al.. (1992). ¹H and ¹³C NMR studies on the antidepressant drug tianeptine. Magnetic Resonance in Chemistry. 30(12). 1212–1219. 2 indexed citations

Labrid, C, et al.. (1989). Structure-Activity Relationships as a Response to the Pharmacological Differences in Beta- Receptor Ligands. American Journal of Hypertension. 2(11 Pt 2). 245S–251S. 8 indexed citations

Beau, Bertrand, et al.. (1988). Cardiovascular and central nervous system effects of rilmenidine (S 3341) in rats. The American Journal of Cardiology. 61(7). D22–D31. 44 indexed citations

Labrid, C, et al.. (1988). Structure-activity relationships of tricyclic antidepressants, with special reference to tianeptine.. PubMed. 11 Suppl 2. S21–31. 18 indexed citations

Labrid, C. (1986). [Cellular disorders induced by ischemia. The effect of trimetazidine].. PubMed. 15(35). 1754–7. 9 indexed citations

Sassine, A, et al.. (1984). Electrophysiologic effects of bepridil in the anesthetized dog studied by endocardiac electrodes. The American Journal of Cardiology. 53(11). 1707–1711. 13 indexed citations

Labrid, C, et al.. (1982). Bepridil-induced modifications of cardiac performance in the anesthetized dog: comparison with nitroglycerin and propranolol.. PubMed. 255(2). 293–308. 2 indexed citations

Ferrier, Marie-Laure, et al.. (1982). STUDIES ON THE BRADYCARDIA INDUCED BY BEPRIDIL. British Journal of Pharmacology. 75(2). 293–300. 26 indexed citations

10.

Debaert, Michel, et al.. (1982). ChemInform Abstract: PHARMACOMODULATION OF THE BENZOXAZOLINONE MODEL BY ARYL‐PIPERAZINE STRUCTURE. Chemischer Informationsdienst. 13(20). 1 indexed citations

11.

Labrid, C, et al.. (1981). Comparative antidysrhythmic profiles of bepridil, amiodarone and disopyramide in the guinea-pig and dog.. PubMed. 249(1). 87–97. 16 indexed citations

12.

Coudert, Gérard, et al.. (1981). 2-Benzodioxinylaminoethanol: a new class of .beta.-adrenergic blocking and antihypertensive agents. Journal of Medicinal Chemistry. 24(8). 994–998. 19 indexed citations

13.

Constantin, Marion, et al.. (1981). [Bepridil, a functional antagonist of beta1-adrenergic stimulation. Dissociated effects on cardiostimulation and lipolysis. (author's transl)].. PubMed. 12(3). 239–54. 1 indexed citations

14.

Labrid, C, et al.. (1979). Some membrane interactions with bepridil, a new antianginal agent.. Journal of Pharmacology and Experimental Therapeutics. 211(3). 546–554. 71 indexed citations

15.

Labrid, C, et al.. (1979). [Prolongation of the effective refractory period on isolated guinea pig atria by some anti-arrhythmia agents: relevance in a comparison of their potentialities].. PubMed. 173(4). 773–80. 1 indexed citations

16.

Labrid, C, et al.. (1977). [Comparative affinity of several standard anti-secretory agents for the intestinal cholinergic receptors of of rats and dogs].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 171(4). 771–7. 1 indexed citations

17.

Labrid, C, et al.. (1977). Activity of a lyophilised whole extract of lamb gastric mucosa in several experimental models of digestive pathology in the rat, the dog and the monkey.. PubMed. 27(4). 837–45. 1 indexed citations

18.

Labrid, C, et al.. (1976). Different membrane mechanisms of action for tiemonium; a comparison with atropine and papaverine.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 223(2). 231–45. 1 indexed citations

19.

Labrid, C, et al.. (1975). Pharmacological properties of 2-(2-chloro-p-toluidino)-2-imidazoline-nitrate (tolonidine), a new antihypertensive agent. II. Action on cardiac contraction, circulatory parameters, autonomic receptors and diuresis.. PubMed. 25(11). 1802–6. 1 indexed citations

20.

Duchêne-Marullaz, P, et al.. (1971). [Some pharmacodynamical properties of niaprazine, a new antihistaminic agent].. PubMed. 26(6). 1203–9. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact